Human papillomavirus (HPV) is responsible for approximately 570 000 cases of cervical cancer worldwide every year.1 Most of these cases of cancer could be prevented, either through early vaccination against high-risk HPV, or by successful screening and management of precursors of cervical cancer. Although childhood vaccination against HPV would be ideal, most women have not received the HPV vaccination and screening for precancerous lesions is generally effective, as long as abnormal results are effectively managed. Despite years of screening, it is still estimated that 13 000 cases of cervical cancer will occur in the United States annually.2
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Feldman S. Screening Options for Preventing Cervical Cancer. JAMA Intern Med. 2019;179(7):879–880. doi:10.1001/jamainternmed.2019.0298
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: